Dr. Oz jumps in as drug exec collapses during Oval Office press conference

Dr. Oz Assists as Drug Executive Collapses During Oval Office Briefing

A press conference in the Oval Office on Thursday was unexpectedly interrupted when Gordon Findlay, global brand director for Novo Nordisk, fainted during remarks about lowering obesity drug prices. President Donald Trump was announcing a partnership with pharmaceutical companies to cut costs on treatments such as Zepbound and Wegovy.

Trump and executives from Eli Lilly and Novo Nordisk had gathered to outline new initiatives aimed at expanding access and reducing prices for obesity medications. As Eli Lilly’s CEO, David Ricks, spoke to reporters, he suddenly looked to the side and asked:

“Are you okay? Gordon, are you okay?”

Moments later, Findlay collapsed to his knees. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, quickly rushed to assist him while President Trump looked on. Members of the media were escorted from the room as staff tended to Findlay.

Health and Human Services officials confirmed they were present during the incident. Roughly 30 minutes later, the press conference resumed, and President Trump gave an update on Findlay’s condition, stating that the executive was recovering.

Summary

During a White House briefing on reducing obesity drug prices, Novo Nordisk’s Gordon Findlay fainted and was aided by Dr. Mehmet Oz before the event briefly paused and later resumed.

more

FOX 2 Detroit FOX 2 Detroit — 2025-11-06

More News